| Product Code: ETC9956187 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Targeted Cancer Therapy Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Targeted Cancer Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Targeted Cancer Therapy Market - Industry Life Cycle |
3.4 United Kingdom (UK) Targeted Cancer Therapy Market - Porter's Five Forces |
3.5 United Kingdom (UK) Targeted Cancer Therapy Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Kingdom (UK) Targeted Cancer Therapy Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United Kingdom (UK) Targeted Cancer Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in the UK |
4.2.2 Technological advancements in targeted cancer therapies |
4.2.3 Growing awareness and adoption of personalized medicine |
4.3 Market Restraints |
4.3.1 High cost associated with targeted cancer therapies |
4.3.2 Stringent regulatory requirements for approval of new therapies |
4.3.3 Limited availability of targeted therapies for certain types of cancer |
5 United Kingdom (UK) Targeted Cancer Therapy Market Trends |
6 United Kingdom (UK) Targeted Cancer Therapy Market, By Types |
6.1 United Kingdom (UK) Targeted Cancer Therapy Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Targeted Cancer Therapy Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Targeted Cancer Therapy Market Revenues & Volume, By Tumor Antigens As Targets of Antibodies, 2021- 2031F |
6.1.4 United Kingdom (UK) Targeted Cancer Therapy Market Revenues & Volume, By Development of Antibodies for Clinical Purposes, 2021- 2031F |
6.1.5 United Kingdom (UK) Targeted Cancer Therapy Market Revenues & Volume, By Complement Dependent Cytotoxicity (CDC), 2021- 2031F |
6.1.6 United Kingdom (UK) Targeted Cancer Therapy Market Revenues & Volume, By Signal Transduction Changes, 2021- 2031F |
6.2 United Kingdom (UK) Targeted Cancer Therapy Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Targeted Cancer Therapy Market Revenues & Volume, By Hospital, 2021- 2031F |
6.2.3 United Kingdom (UK) Targeted Cancer Therapy Market Revenues & Volume, By Clinic, 2021- 2031F |
7 United Kingdom (UK) Targeted Cancer Therapy Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Targeted Cancer Therapy Market Export to Major Countries |
7.2 United Kingdom (UK) Targeted Cancer Therapy Market Imports from Major Countries |
8 United Kingdom (UK) Targeted Cancer Therapy Market Key Performance Indicators |
8.1 Patient survival rates for specific targeted therapies |
8.2 Number of clinical trials for new targeted cancer therapies in the UK |
8.3 Adoption rate of targeted therapies among oncologists in the UK |
9 United Kingdom (UK) Targeted Cancer Therapy Market - Opportunity Assessment |
9.1 United Kingdom (UK) Targeted Cancer Therapy Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Kingdom (UK) Targeted Cancer Therapy Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United Kingdom (UK) Targeted Cancer Therapy Market - Competitive Landscape |
10.1 United Kingdom (UK) Targeted Cancer Therapy Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Targeted Cancer Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here